ecrin-mdr-crcClinical2002Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2019706Spain4OxaliplatinCapecitabineColorectal cancer, capecitabine, oxaliplatin, 5-fluorouracilFluorouracilECRIN MDRCompletedfalseSafety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal CancerThe purpose of this study is to determine time to disease progression of combination therapy with capecitabine and oxaliplatin (XELOX) vs. oxaliplatin and 5-fluorouracil in continous infusion (5-FU CI) as first line treatment in advanced or metastatic colorectal cancer2002-04-152019706NCT00202774